ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Enliven Therapeutics Inc

Enliven Therapeutics Inc (ELVN)

0.00
0.00
(0.00%)
Closed June 30 3:00PM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -11.52M-4.83M-3.26M-16.42M-20.13M-24.25M-22.73M-25.99M
Pre Tax Income -11.45M-4.61M32.27M-14.72M-16.72M-20.77M-19.37M-22.74M
Net Income -11.45M-4.61M32.19M-14.72M-16.72M-20.77M-19.37M-22.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -11.56M-4.85M31.76M-16.42M-20.13M-24.26M-22.74M-25.99M
EBITDA -11.04M-4.73M-3.26M-16.35M-20.06M-24.17M-22.65M-25.91M
Year End December 30 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000000
Operating Income -10.68M-24.12M-41.7M-51.44M-34.27M-83.53M
Pre Tax Income -11.34M-23.46M-41.36M-51.38M1.58M-71.58M
Net Income -11.34M-23.46M-49.22M-51.38M1.49M-71.58M
Preferred Dividends 00-7.86M000
Basic Earnings Per Share (EPS) -16.15-2.275-2.805-1.9550.057-1.737
EBIT -11.34M-24.04M-41.84M-51.62M633k-83.55M
EBITDA -10.68M-24.08M-41.6M-51.34M-33.66M-83.23M